Engineering Regulable Escherichia coliβ-Galactosidases as Biosensors for Anti-HIV Antibody Detection in Human Sera*

The activity of engineered, peptide-displaying enzymes is modulated by binding to specific anti-peptide antibodies. This new concept of a quantitative antibody detection system allows test kits to be set up for fast diagnosis of infectious diseases. To develop a quick and homogeneous assay for the detection of human immunodeficiency virus (HIV) infection, we have explored two acceptor sites of the bacterial Escherichia coli β-galactosidase for the accommodation of HIV antigenic peptides. Two overlapping epitopes (namely P1 and P2) from the gp41 envelope glycoprotein, contained in different sized peptides, were inserted in the vicinity of the enzyme active site to generate a set of hybrid, enzymatically active β-galactosidases. Regulable enzymes of different responsiveness to monoclonal antibody binding were generated with both acceptor sites tested. These biosensors were also sensitive to immune sera from HIV-infected patients. Modeling data provide insight into the structural modifications in the vicinity of the active site induced by peptide insertion that strongly affect the responsiveness of the engineered proteins through different parameters of their catalytic properties.

[1]  R. E. Huber,et al.  Substitutions for Gly-794 show that binding interactions are important determinants of the catalytic action of beta-galactosidase (Escherichia coli). , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[2]  A. Ullmann.  One-step purification of hybrid proteins which have β-galactosidase activity , 1984 .

[3]  P. Henklein,et al.  Interaction between a Fab fragment against gp41 of human immunodeficiency virus 1 and its peptide epitope: characterization using a peptide epitope library and molecular modeling. , 1995, Protein engineering.

[4]  Antonio Villaverde,et al.  Uses of β-galactosidase tag in on-line monitoring production of fusion proteins and gene expression in Escherichia coli , 1993 .

[5]  G. Linette,et al.  Induction of anti‐HIV neutralizing antibodies by synthetic peptides. , 1986, The EMBO journal.

[6]  U. Rinas,et al.  Comparison of temperature- and isopropyl-β-d-thiogalacto-pyranoside-induced synthesis of basic fibroblast growth factor in high-cell-density cultures of recombinant Escherichia coli , 1995 .

[7]  J. Miller,et al.  Effects of amino acid substitutions at the active site in Escherichia coli beta-galactosidase. , 1988, Genetics.

[8]  A. Villaverde,et al.  Engineering of solvent‐exposed loops in Escherichia coli β‐galactosidase , 1998 .

[9]  A. Villaverde,et al.  β-Galactosidase Enzymatic Activity as a Molecular Probe to Detect Specific Antibodies* , 1996, The Journal of Biological Chemistry.

[10]  C. Y. Wang,et al.  Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Villaverde,et al.  Enhanced production of pL-controlled recombinant proteins and plasmid stability in Escherichia coli RecA+ strains. , 1993, Journal of biotechnology.

[12]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[13]  K. Steimer,et al.  Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). , 1985, Science.

[14]  A. Villaverde,et al.  Distinct mechanisms of antibody‐mediated enzymatic reactivation in β‐galactosidase molecular sensors , 1998, FEBS letters.

[15]  J. Monod,et al.  Genetic regulatory mechanisms in the synthesis of proteins. , 1961, Journal of molecular biology.

[16]  Patrice Soumillion,et al.  Engineering a regulatable enzyme for homogeneous immunoassays , 1999, Nature Biotechnology.

[17]  R. E. Huber,et al.  The β-Galactosidase (Escherichia coli) Reaction Is Partly Facilitated by Interactions of His-540 with the C6 Hydroxyl of Galactose* , 1996, The Journal of Biological Chemistry.

[18]  L. Kelley,et al.  An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.

[19]  Insertion of a 27 amino acid viral peptide in different zones of Escherichia coli beta-galactosidase: effects on the enzyme activity. , 1994, FEMS microbiology letters.

[20]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[21]  R. E. Huber,et al.  Site-Directed Substitutions Suggest That His-418 of β-Galactosidase (Escherichia coli) Is a Ligand to Mg2+ , 1994 .

[22]  J. Coligan,et al.  A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. , 1985, Science.

[23]  K. Otto,et al.  Sequence of the lacZ gene of Escherichia coli. , 1983, The EMBO journal.

[24]  R. Kennedy,et al.  Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. , 1986, Science.

[25]  S. Wodak,et al.  Extracting information on folding from the amino acid sequence: accurate predictions for protein regions with preferred conformation in the absence of tertiary interactions. , 1992, Biochemistry.

[26]  R. E. Huber,et al.  Structural comparisons of TIM barrel proteins suggest functional and evolutionary relationships between β‐galactosidase and other glycohydrolases , 2008, Protein science : a publication of the Protein Society.

[27]  J. Nelson,et al.  Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. , 1987, The Journal of infectious diseases.

[28]  B. Matthews,et al.  Three-dimensional structure of β-galactosidase from E. coli. , 1994, Nature.

[29]  J. Groopman,et al.  Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. , 1985, Science.

[30]  R. E. Huber,et al.  Multiple replacements establish the importance of tyrosine-503 in beta-galactosidase (Escherichia coli). , 1990, Archives of biochemistry and biophysics.

[31]  N. Doi,et al.  Insertional gene fusion technology , 1999, FEBS letters.

[32]  Paul H. Bessette,et al.  Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Corrah,et al.  Human immunodeficiency virus type 2 (HIV2). , 1990, Blood reviews.

[34]  R. Gallo,et al.  Human T-lymphotropic retroviruses , 1985, Nature.

[35]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .